HUMAN 3P RECESSIVE ONCOGENES
人类 3P 隐性癌基因
基本信息
- 批准号:2443280
- 负责人:
- 金额:$ 32.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-09-13 至 2000-06-30
- 项目状态:已结题
- 来源:
- 关键词:DNA directed DNA polymerase DNA footprinting apoptosis athymic mouse autosomal recessive trait cell growth regulation enzyme activity gene deletion mutation gene expression human genetic material tag human tissue lung neoplasms molecular cloning molecular pathology neoplasm /cancer genetics northern blottings nucleic acid sequence oncogenes polymerase chain reaction protein sequence pulsed field gel electrophoresis single strand conformation polymorphism southern blotting statistics /biometry telomerase telomere tissue /cell culture
项目摘要
DESCRIPTION (Adapted from the Investigator's Abstract): This is a new
proposal to identify and study the function of a putative recessive tumor
suppressor gene or genes in 3p21.3 important in the development of lung
cancers. Evidence for such a tumor suppressor comes from studies showing
the early loss of 3p21 alleles in preneoplasia, and allele loss of 3p genes
in 70-80% of both small cell and non-small cell lung cancers. In specific
aim I it is proposed to clone the gene using a series of resources including
a set of homozygous deletions in lung tumor cell lines defining a 350 kb and
potentially 30 kb critical region, and a high resolution physical and
transcription map with 25 cDNA clones already identified in this region.
Specific aim 2 is to determine functional characteristics of this locus by
introduction of portions of chromosome 3p into human lung cancer lines
bearing a 3p21.3 abnormality, and testing for suppression of tumorigenicity
using nude mice, soft agarose culture and studies of apoptosis. In specific
aim 3 the applicant plans to follow up on an observation that this region
might be involved in suppressing telomerase activity by investigating
telomere length and telomerase function in lung cancer cells altered by gene
transfer.
描述(改编自研究者摘要):这是一个新的
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN D. MINNA其他文献
JOHN D. MINNA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN D. MINNA', 18)}}的其他基金
Developing ASCL1 and NeuroD1 lineage oncogene targeted therapy for small cell lung cancer
开发针对小细胞肺癌的 ASCL1 和 NeuroD1 谱系癌基因靶向治疗
- 批准号:
10240702 - 财政年份:2017
- 资助金额:
$ 32.79万 - 项目类别:
Developing ASCL1 and NeuroD1 lineage oncogene targeted therapy for small cell lung cancer
开发针对小细胞肺癌的 ASCL1 和 NeuroD1 谱系癌基因靶向治疗
- 批准号:
9767080 - 财政年份:2017
- 资助金额:
$ 32.79万 - 项目类别:
P-1: Molecular Signatures for Individualizing Lung Cancer Therapy
P-1:个体化肺癌治疗的分子特征
- 批准号:
8731332 - 财政年份:2013
- 资助金额:
$ 32.79万 - 项目类别:
P-1: Molecular Signatures for Individualizing Lung Cancer Therapy
P-1:个体化肺癌治疗的分子特征
- 批准号:
7507375 - 财政年份:2008
- 资助金额:
$ 32.79万 - 项目类别:
IDENTIFICATION OF 3P RECESSIVE ONCOGENES IN LUNG CANCER
肺癌中 3P 隐性癌基因的鉴定
- 批准号:
6395787 - 财政年份:2000
- 资助金额:
$ 32.79万 - 项目类别:
相似海外基金
DNA footprinting of a plant defense gene family; to support visit by A.M. Yorkin, Department of Genetics, St. Petersburg State University, St. Petersburg, Russia
植物防御基因家族的 DNA 足迹;
- 批准号:
147394-1992 - 财政年份:1993
- 资助金额:
$ 32.79万 - 项目类别:
International: Foreign Researcher (H)